AbSci Corp (ABSI) News

AbSci Corp (ABSI): $3.35

-0.09 (-2.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ABSI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Filter ABSI News Items

ABSI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ABSI News Highlights

  • For ABSI, its 30 day story count is now at 4.
  • Over the past 6 days, the trend for ABSI's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • DRUG, WASH and LI are the most mentioned tickers in articles about ABSI.

Latest ABSI News From Around the Web

Below are the latest news stories about Absci Corp that investors may wish to consider to help them evaluate ABSI as an investment opportunity.

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences. Truist Life Sciences AI Symposium – Biotech & ToolsPanel Discussion on Tuesday, March 1st at 7:10 a.m. Pacific Time / 10:10 a.m. Eastern TimeInterested parties may view the Sympo

Yahoo | February 17, 2022

Future Outlook And Stock Price Performance For Absci Corporation (NASDAQ: ABSI)

In the last trading session, 1.42 million shares of the Absci Corporation (NASDAQ:ABSI) were traded. Most recently the company’s share price was $8.83, and it changed around $0.05 or 0.57% from the last close, which brings the market valuation of the company to $799.73M. ABSI currently trades at a discount to its 52-week high of … Future Outlook And Stock Price Performance For Absci Corporation (NASDAQ: ABSI) Read More »

Marketing Sentinel | February 16, 2022

Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

VANCOUVER, Wash., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

GlobeNewswire | February 11, 2022

Absci (ABSI) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

The following slide deck was published by Absci Corporation in conjunction with this event.

Seeking Alpha | January 12, 2022

Biotech Stock Roundup: BIIB's AD Drug Update, AMGN's Drug Approval & Other Updates

Regulatory and other pipeline updates from Biogen (BIIB) and AMGN are among a few key highlights from the biotech sector during the past week.

Yahoo | January 12, 2022

Regional biotech and health firms raked in record investments in 2021

All told, there was about $324 million in VC investments in biotech and digital health companies last year, according to data compiled by PitchBook and The Business Journal. Absci Corp., a synthetic biology company based in Vancouver that went public last July, led the pack, with a $125 million investment led by New York-based Casdin Capital and Redmile Group, on the heals of a $65 million deal in October 2020.

Yahoo | January 10, 2022

Absci (ABSI) Inks Research Agreement With Merck, Stock Up

Absci (ABSI) signs a deal with Merck for using its AI-powered drug creation platform to produce enzymes for Merck's biomanufacturing applications with an option for the development of three novel drugs.

Yahoo | January 10, 2022

ABSI Stock: 7 Things for Investors to Know About the Merck Deal That Has Absci Shares Flying Today

Absci (ABSI) stock is flying higher on Friday after announcing a major research collaboration agreement with Merck (MRK).

William White on InvestorPlace | January 7, 2022

DOGZ Alert: Why Pet Penny Stock Dogness Is Running Higher Today

Dogness (DOGZ) stock is on a run Friday as investors react to recent volatility surrounding the shares alongside heavy trading.

William White on InvestorPlace | January 7, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it off with an overview of the biggest pre-market stock movers for Friday!

William White on InvestorPlace | January 7, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4843 seconds.